Every pharmacy claim benchmarked against the National Average Drug Acquisition Cost (NADAC). Detect MAC list manipulation, PBM-owned pharmacy steering, and generic drug overcharges in real-time. Generate audit-ready evidence packages automatically.
Every prescription claim automatically cross-referenced against federal NADAC benchmarks. Variance detection, pattern analysis, and audit automation in a single platform.
Continuous comparison of every pharmacy claim against federally-published National Average Drug Acquisition Cost benchmarks. Instant detection of MAC list manipulation and spread pricing schemes.
Machine learning algorithms identify pricing patterns that deviate from NADAC by 50%+. Flags generic drug overcharges, PBM-owned pharmacy steering, and specialty drug margin inflation.
Visual breakdown showing where PBM margin is hidden — maintenance generics, mail-order steering, specialty tier manipulation. Quantifies the true cost of spread pricing across your formulary.
One-click creation of legally-binding audit request letters citing specific contract violations. Includes NDC-level evidence, variance calculations, and CAA 2026 §3101 compliance language.
Real anomalies from a recent audit. These generic maintenance drugs show 1,000%+ variance between NADAC acquisition cost and PBM billed amounts — classic MAC list manipulation.
| Drug / NDC | NADAC Cost | PBM Billed | Spread | Variance |
|---|---|---|---|---|
Atorvastatin 40mg 00093-3147-01 | $3.15 | $45.20 | $42.05 | 1,335% |
Lisinopril 20mg 00093-7152-56 | $1.50 | $22.00 | $20.50 | 1,366% |
Rosuvastatin 20mg 68180-0720-01 | $2.80 | $38.50 | $35.70 | 1,275% |
This represents 3 of 4,218 flagged anomalies from a single quarter.Get your full analysis →
From one-time analysis to continuous monitoring with audit automation. All plans include NADAC benchmarking, spread detection, and evidence generation.
Single-period NADAC benchmarking report
Quarterly NADAC monitoring + audit automation
Multi-entity monitoring + API access